GAM
Groupama Asset Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.1M | Buy |
104,618
+3,396
| +3% | +$2.63M | 1.34% | 18 |
|
|
2025
Q1 | $83.3M | Buy |
101,222
+9,384
| +10% | +$7.72M | 1.66% | 15 |
|
|
2024
Q4 | $71.1M | Buy |
91,838
+3,373
| +4% | +$2.61M | 1.45% | 17 |
|
|
2024
Q3 | $62.9M | Buy |
88,465
+458
| +0.5% | +$326K | 1.63% | 16 |
|
|
2024
Q2 | $79.7M | Buy |
88,007
+6,975
| +9% | +$6.32M | 1.08% | 21 |
|
|
2024
Q1 | $71.8M | Sell |
81,032
-16,372
| -17% | -$14.5M | 1.31% | 19 |
|
|
2023
Q4 | $56.8M | Buy |
+97,404
| New | +$56.8M | 1.48% | 16 |
|